Delivery Order SPE2DB20D1100-SPE2DB25FE1L8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,783.57 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count) with a completion deadline of September 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply framework. The contractor, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a $1,471.36 delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 18 mg tablets (100-count) on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Methylphenidate ER 54 mg tablets (100-count bottles) with a ceiling value of $1,386.06. This firm fixed-price delivery order, which is expected to be completed by July 30, 2025, represents a competitive procurement with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $1,654.20 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Methylphenidate ER 54 mg tablets in quantities of 100 units. This contract employs firm fixed price terms with an ultimate completion date of July 15, 2025, and is classified as a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Methylphenidate ER 54 mg tablets (100-count units) with a ceiling value of $1,391.74. This is a firm fixed-price delivery order issued under a competitive procurement with no set-aside designation. The award reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs, particularly for military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $1,073.04 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 mg tablets (100-count units). This order, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a firm fixed-price, competitively awarded contract with no set-aside designation. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,386.32 to AmerisourceBergen Drug Corp for 100 tablets of Methylphenidate ER 54 mg on September 18, 2025, with completion scheduled for September 19, 2025. This firm fixed price delivery order carries no set-aside designation and represents a competitively awarded transaction under the company's existing contract vehicle. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Methylphenidate ER 54 mg tablets (100-count bottles) under a firm fixed-price contract with a ceiling value of $1,431.52. This is a non-set-aside competitive award, with an ultimate completion date of June 3, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count) under a firm fixed-price contract valued at $1,362.35. This non-set-aside competitive award, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a routine pharmaceutical procurement through the federal medical supply chain. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $4,180.38 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count units). This firm fixed-price contract, awarded on March 18, 2025, with an ultimate completion date of March 19, 2025, represents a standard pharmaceutical procurement supporting federal medical supply needs. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1L8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,474.45 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count packaging). This non-competitive, firm fixed-price delivery order was executed on August 19, 2025, with an ultimate completion date of August 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the company's existing federal contract framework. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp maintains an extensive portfolio supplying medications, vaccines, and medical devices to support military and veteran healthcare systems. The parent IDC enables the company to fulfill diverse pharmaceutical requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems on a global basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 8/19/25 |